Cargando…

EE632 Winning the COVID-19 Vaccine Race: How to Launch a Premium Priced COVID-19 Vaccine in a Competitive and Saturated Cost-Effectiveness Market

Detalles Bibliográficos
Autores principales:	Folorunso, R, Vyas, H, Perez, L, O'Brien, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747377/ http://dx.doi.org/10.1016/j.jval.2022.09.871

Ejemplares similares

EE179 Key Drivers of the Economically Justifiable Price of the COVID-19 Vaccine in England
por: Aballea, S, et al.
Publicado: (2022)

COVID-19 and commodity pricing premium: Evidence from the Chinese market
por: Zhang, Lu, et al.
Publicado: (2023)

EE329 The Value-Based Price for a Bivalent COVID-19 Booster Vaccine in the United Kingdom
por: Kohli, M., et al.
Publicado: (2023)

EE564 Study on the Value Pricing of COVID-19 Vaccine in China Based on the Evidence of Cost-Effectiveness Analysis
por: Fu, Y., et al.
Publicado: (2023)

Managing new premium-priced medicines in Europe
por: Permanand, Govin, et al.
Publicado: (2015)

Race for a COVID-19 vaccine
Publicado: (2020)

COVID-19: The race for a vaccine
por: Lockey, Emily
Publicado: (2020)

PO-632-07 EFFECTIVENESS OF THE WEARABLE CARDIOVERTER DEFIBRILLATOR IN PATIENTS WITH COVID-19
por: Bianco, Nicole, et al.
Publicado: (2022)

Launching COVID-19 vaccination in Saudi Arabia: Lessons learned, and the way forward
por: Assiri, Abdullah, et al.
Publicado: (2021)

Analysing the Launch of COVID-19 Vaccine National Rollouts: Nine Case Studies
por: Gannon, John, et al.
Publicado: (2021)

EE188 COVID-19 Vaccine Hesitancy Among Early Adaptors in Jordan
por: Muflih, S
Publicado: (2022)

The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation
por: Wang, Jieliang, et al.
Publicado: (2020)

Vaccine or monoclonal therapy: which is the winning weapon against COVID-19?
por: Lo Muzio, Lorenzo, et al.
Publicado: (2021)

The race to make a COVID-19 vaccine
por: Boseley, Sarah
Publicado: (2021)

Efficacy of COVID-19 vaccines by race and ethnicity
por: Salari, N., et al.
Publicado: (2022)

Acceptance of COVID-19 vaccine among healthcare workers before the launch of vaccine in India: An online survey
por: Dkhar, Sabira Aalia, et al.
Publicado: (2022)

Pricing the COVID-19 vaccine: A mathematical approach()
por: Martonosi, Susan E., et al.
Publicado: (2021)

Value-based pricing of a COVID-19 vaccine
por: Gandjour, Afschin
Publicado: (2022)

Boosting with variant-matched vaccines: an opportunity to win the race against Omicron
por: Wang, Jiayu, et al.
Publicado: (2022)

EE7 Economic Evaluation of COVID-19 Vaccines: A Targeted Literature Review
por: Addae, A, et al.
Publicado: (2022)

EE335 The Hospitalization Burden of COVID-19 in Patients with NSCLC: Differential Impact of Vaccination
por: Richy, F, et al.
Publicado: (2022)

COVID-19 vaccines: A race against time
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2021)

The race between vaccination and evolution of COVID-19 variants
por: Burki, Talha Khan
Publicado: (2021)

The Race for Global Equitable Access to COVID-19 Vaccines
por: Md Khairi, Lukman Nul Hakim, et al.
Publicado: (2022)

An overview of procurement, pricing, and uptake of COVID-19 vaccines in Pakistan
por: Siddiqui, Adeel, et al.
Publicado: (2021)

Covid-19 Vaccination during Pregnancy — Two for the Price of One
por: Rasmussen, Sonja A., et al.
Publicado: (2022)

EE98 Health Economic Evaluation of COVID-19 Vaccines: A Systematic Literature Review
por: Li, Y., et al.
Publicado: (2023)

COVID-19 database launched in the USA
por: Fyfe, Ian
Publicado: (2021)

Issuing bonds during the Covid-19 pandemic: Was there an ESG premium?()
por: Ferriani, Fabrizio
Publicado: (2023)

Back to the Future: Can Vaccines Win the Long-Term Fight Against COVID-19?
por: Ertl, Hildegund C. J., et al.
Publicado: (2022)

Exploring the Effect of Market Conditions on Price Premiums in the Online Health Community
por: Li, Chaoran, et al.
Publicado: (2020)

COVID‐19 vaccine hesitancy: Race/ethnicity, trust, and fear
por: Willis, Don E., et al.
Publicado: (2021)

Policy options discussed for pricing novel COVID-19 vaccines/treatment
Publicado: (2020)

High SARS-CoV-2 seroprevalence in Karaganda, Kazakhstan before the launch of COVID-19 vaccination
por: Kadyrova, Irina, et al.
Publicado: (2022)

Preferences for COVID-19 vaccination information and location: Associations with vaccine hesitancy, race and ethnicity
por: Fisher, Kimberly A., et al.
Publicado: (2021)

Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: A win-win bet with Health Authorities!
por: Jonville-Bera, Annie Pierre, et al.
Publicado: (2023)

EE71 Cost-Effectiveness of COVID-19 Vaccination in Colombia: A Micro-Simulation Modelling Analysis
por: Castañeda-Orjuela, C, et al.
Publicado: (2022)

EE540 Cost-Effectiveness of Vaccines Targeting Infectious Diseases - Has COVID-19 Changed the Landscape?
por: Pitman, R, et al.
Publicado: (2022)

632. Recurrent Pneumococcal Meningitis in Adults
por: Lauter, Carl, et al.
Publicado: (2018)

Slow and steady wins the race: Better walking than running. The turtle's lesson in the times of COVID-19
por: Sciomer, S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t7c8sigsojg23fflsc4j05d4bl